2026: AI Dominates Taylor Wessing’s Perspective On Commercial Opportunities

 
• By Ashley Yeo
  
Japan cell therapy
Lawyers at Taylor Wessing see AI as crucial to commercial opportunities this year. (Shutterstock)

More from Legal & IP

More from Medtech Insight